Astroblastoma: Beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 451-460

  Mellai, Marta ^a   Piazzi, Angela ^a   Casalone, Cristina ^b   Grifoni, Silvia ^b   Melcarne, Antonio ^c   Annovazzi, Laura ^a   Cassoni, Paola ^d   Denysenko, Tetyana ^a   Valentini, Maria Consuelo ^c   Cistaro, Angelina ^e,f   Schiffer, Davide ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b LIGURIA E VALLE D AOSTA   (Italy)

^c CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Euromedic Inc   (Italy)

^f INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

Author keywords

Cell lines; Genetics; Gliomas; Histology

Indexed keywords

ADENINE; B RAF KINASE; BETA TUBULIN; BETAIII TUBULIN; CD133 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; CELL PROTEIN; GALACTOSYLCERAMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GUANINE; ISOCITRATE DEHYDROGENASE 1; KI 67 ANTIGEN; NESTIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MUSASHI 1; PROTEIN P53; RE1 SILENCING TRANSCRIPTION FACTOR; TEMOZOLOMIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VIMENTIN;

ADHERENT CELL; AGED; ALLELIC IMBALANCE; ARTICLE; ASTROBLASTOMA; ASTROCYTIC GLIOMA; ASTROCYTOMA; ATAXIC APHASIA; BLASTOMA; BRAIN CALCIFICATION; BRAIN CANCER; BRAIN EDEMA; BRAIN SURGERY; CANCER GENETICS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CELLULAR DISTRIBUTION; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 9P; CODON; CONTRAST ENHANCEMENT; DEATH; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DNA METHYLATION; EGFR GENE; EMP3 GENE; EPENDYMOMA; EPIGENETICS; EXON; FEMALE; GEMISTOCYTIC GLIOMA; GENE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HEADACHE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; INTRON; MALE; MENTAL DISEASE; MGMT GENE; MISSENSE MUTATION; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PERIVASCULAR ARRANGEMENT; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; SEIZURE; SEQUENCE ANALYSIS; TP53 GENE; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84923186801     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S71384     Document Type: Article

References (37)

1. Bailey P. Cellular types in primary tumors of the brain. In: Penfield W, editor. Cytology and Cellular Pathology of The Nervous System. New York, PA: Hoeber; 1932:905–951.
2. Kernohan JW, Mabon RF, Svien HJ, et al. A simplified classification of the gliomas. Proc Staff Meet Mayo Clin. 1949;24(3):71–75.
3. Zülch KJ. Biologie und Pathologie der Hirn Geschwülste [Biology and pathology of brain tumors]. In: Zülch KJ, Christensen E, editors. Pathologische Anatomie der Raumbeengenden Intrakraniellen Prozesse. Berlin: Springer; 1956:1–702. German.
4. Russell DS, Rubinstein LJ. Pathology of Tumours of the Nervous System. 5th ed. London: Edward Arnold; 1989.
5. Kubota T, Hirano A, Sato K, Yamamoto S. The fine structure of astroblastoma. Cancer. 1985;55(4):745–750.
6. Eng LF, Rubinstein LJ. Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem. 1978;26(7):513–522.
7. Velasco ME, Dahl D, Roessmann U, Gambetti P. Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer. 1980;45(3):484–494.
8. Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007;17(3):304–307.
9. Sughrue ME, Choi J, Rutkowski MJ, et al. Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci. 2011;18(6):750–754.
10. Bonnin JM, Rubinstein LJ. Astroblastomas: a pathological study of 23 tumors, with a postoperative follow-up in 13 patients. Neurosurgery. 1989;25(1):6–13.
11. Husain AN, Leestma JE. Cerebral astroblastoma: immunohistochemical and ultrastructural features. Case report. J Neurosurg. 1986;64(4): 657–661.
12. Burger PC, Scheithauer BW. Tumor of the central nervous system. In: Washington, DC: Armed Forces Institute of Pathology, editor. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 3rd series, fascicle 10; 1994:146–148. 77–96.
13. Aldape KD, Rosenblum IK. Astroblatoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC; 2007:88–89.
14. Kujas M, Faillot T, Lalam T, Roncier B, Catala M, Poirier J. Astroblastomas revisited. Report of two cases with immunocytochemical and electron microscopic study. Histogenetic considerations. Neuropathol Appl Neurobiol. 2000;26(3):295–298.
15. Port JD, Brat DJ, Burger PC, Pomper MG. Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma. AJNR Am J Neuroradiol. 2002;23(2):243–247.
16. Alaraj A, Chan M, Oh S, Michals E, Valyi-Nagy T, Hersonsky T. Astroblastoma presenting with intracerebral hemorrhage misdiagnosed as dural arteriovenous fistula: review of a rare entity. Surg Neurol. 2007;67(3):308–313.
17. Fu YJ, Taniguchi Y, Takeuchi S, et al. Cerebral astroblastoma in an adult: an immunohistochemical, ultrastructural and genetic study. Neuropathology. 2013;33(3):312–319.
18. Shakur SF, McGirt MJ, Johnson MV, et al. Angiocentric glioma: a case series. J Neurosurg Pediatr. 2009;3(3):179–202.
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC; 2007.
20. Mellai M, Piazzi A, Caldera V, et al. IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors. J Neurooncol. 2011;105(2):345–357.
21. Caldera V, Mellai M, Annovazzi L, et al. Antigenic and genotypic similarity between primary glioblastomas and their derived neurospheres. J Oncol. 2011;2011:314962.
22. Mellai M, Monzeglio O, Piazzi A, et al. MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors. J Neurooncol. 2012;107(3):617–631.
23. Mellai M, Piazzi A, Caldera V, et al. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas. Biomed Res Int. 2013;2013:756302.
24. Galli R. The neurosphere assay applied to neural stem cells and cancer stem cells. Methods Mol Biol. 2013;986:267–277.
25. Schiffer D, Cravioto H, Giordana MT, Migheli A, Pezzulo T, Vigliani MC. Is polar spongioblastoma a tumor entity? J Neurosurg. 1993;78(4):587–591.
26. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 2012;60(3):502–514.
27. Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PC. Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol. 2000;10(3):342–352.
28. Navarro R, Reitman AJ, de León GA, Goldman S, Marymont M, Tomita T. Astroblastoma in childhood: pathological and clinical analysis. Childs Nerv Syst. 2005;21(3):211–220.
29. Rubinstein LJ, Herman MM. The astroblastoma and its possible cytogenic relationship to the tanycyte. An electron microscopic, immunohistochemical, tissue- and organ-culture study. Acta Neuropathol. 1989;78(5):472–483.
30. Kubota T, Sato K, Arishima H, Takeuchi H, Kitai R, Nakagawa T. Astroblastoma: immunohistochemical and ultrastructural study of distinctive epithelial and probable tanycytic differentiation. Neuropathology. 2006;26(1):72–81.
31. Facchino S, Abdouh M, Bernier G. Brain cancer stem cells: current status on glioblastoma multiforme. Cancers (Basel). 2011;3(2): 1777–1797.
32. de Almeida Sassi F, Lunardi Brunetto A, Schwartsmann G, Roesler R, Abujamra AL. Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche. J Oncol. 2012;2012:537861.
33. Olar A, Aldape KD. Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol. 2014;232(2):165–177.
34. Schiffer D, Mellai M, Annovazzi L, Piazzi A, Monzeglio O, Caldera V. Glioblastoma cancer stem cells: basis for a functional hypothesis. Stem Cell Discovery. 2012;2(3):122–131.
35. Zipori D. The nature of stem cells: state rather than entity. Nat Rev Genet. 2004;5(11):873–878.
36. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006;6(6):425–436.
37. Filatova A, Acker T, Garvalov BK. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta. 2013;1830(2):2496–2508.